Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home ...

Laboratory Corporation of America Holdings LH or LabCorp announced the launch of an at-home collection kit for diabetes screening, which measures hemoglobin A1c (HbA1c) from a small blood sample. With ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

BURLINGTON, N.C.--(BUSINESS WIRE)--There is a new and convenient way for millions of individuals to assess whether they are at risk for developing diabetes. Labcorp (NYSE: LH), a leading global life ...

(RTTNews) - Life sciences company Labcorp (LH) announced Wednesday the receipt of Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a combined at-home collection ...

Labcorp launched a first-of-its-kind, at-home diabetes risk testing kit. Labcorp is the only commercial lab to offer Weavr Health’s Velvet blood collection device, according to a May 16 news release.

The test includes the Weavr Velvet blood collection device, which separates the sample into its red blood cell and plasma components. Labcorp has launched the Diabetes Risk (HbA1c) at-home collection ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the receipt of Emergency Use Authorization (EUA) from the U.S. Food and Drug ...

Home self-test kits to detect COVID-19 offer convenience and fast results. Several players in the market promote their own versions. For example, with a prescription and $25, BinaxNOW provides their ...